Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.

Abstract

BACKGROUND Polymorphonuclear neutrophils (PMNs) have gained attention as critical mediators of acute coronary syndromes (ACS). Myeloperoxidase (MPO), a hemoprotein abundantly expressed by PMNs and secreted during activation, possesses potent proinflammatory properties and may contribute directly to tissue injury. However, whether MPO also provides… (More)

Cite this paper

@article{Baldus2003MyeloperoxidaseSL, title={Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.}, author={Stephan Ernst Baldus and Christopher Heeschen and Thomas Meinertz and Andreas Michael Zeiher and Jason P. Eiserich and Thomas F. M{\"u}nzel and Maarten L. Simoons and Christian Wilhelm Hamm}, journal={Circulation}, year={2003}, volume={108 12}, pages={1440-5} }